首页 >
法规速递
-
Page: Development of anti-cancer medicinal products in paediatric patients - Scientific guideline-2026/3/13
2026-03-16查看详情 > -
国家药监局关于批准注册272个医疗器械产品的公告（2026年3月）（2026年第38号）-2026/4/13
2026-04-14查看详情 > -
关于公开征求《蔗糖铁注射液生物等效性研究技术指导原则（征求意见稿）》意见的通知-2026/5/29
2026-05-31查看详情 > -
Page: Worksharing: questions and answers-2026/7/13
2026-07-14查看详情 > -
Document: Timetable: Post-authorisation measure (PAM) assessed by CHMP-2026/8/18
2026-08-19查看详情 > -
Regulatory and procedural guideline: European Medicines Agency certificates of medicinal products - instructions on how to fill in the application form (updated)-2023/01/16
2023-01-16查看详情 > -
Scientific guideline: Qualification Opinion for Stride velocity 95th centile as primary endpoint in studies in ambulatory Duchenne Muscular Dystrophy studies-2023/7/31
2023-08-02查看详情 > -
国家药监局 人力资源社会保障部关于印发执业药师继续教育暂行规定的通知 国药监人〔2024〕3号-2024/1/11
2024-03-12查看详情 > -
Document: Guidance on Irish language derogation ending on 1 January 2022-2025/1/31
2025-02-05查看详情 > -
Document: Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting 24-27 February 2025-2025/3/11
2025-03-12查看详情 >
